These Employers Work with Vendors (& #PBMs ) that Designate Certain #Rx ’s as “Non-Essential Health Benefits” & Extract Copay Assistance meant for Patients for Themselves. U.S. Department of Labor must #ProtectACA : bit.ly/3vEnuDS

Learn how health centers, clinics, pharmacies, & health depts can increase #PrEP by leveraging existing programs & #insurance . Join HIV+Hepatitis Policy Institute Allies In Hope Houston @avitapharmacy Colorado Department of Public Health & Environment East Boston Neighborhood Health Center MISTR on 4/19 in Seattle: hivhep.org/Biomedical2024

We were pleased that S2720 passed the RI Senate unanimously, restricting the use of #copayaccumulator progs & ensuring that #allcopayscount , and we hope the House will pass H 8041 so RI can join 20 states, PR & DC to prevent #insurers from double-dipping: bit.ly/49j3PHe

We are looking forward to our “Scaling Up PrEP Now by Leveraging Existing Programs” workshop on 4/19 in Seattle NMAC #2024BHPS Learn more: hivhep.org/Biomedical2024

.@HHSgov is to be applauded for final #NBPP2025 rule, which moves to end insurance company schemes to classify drugs as “non-essential health benefits” in order to pocket copay assistance & evade #ACA #costsharing protections: bit.ly/3vEnuDS

Good update via @iqvia_global: Fewer patients face #accumulators , but more hit by maximizers (esp. for oncology & MS). Decline in autoimmune due to industry response? 👇

Meanwhile, #PBMs , plans, and vendors still profiting from patient support funds!

==> drugch.nl/3TIoqz5

Join HIV+Hepatitis Policy Institute Allies In Hope Houston @avitapharmacy Colorado Department of Public Health & Environment East Boston Neighborhood Health Center MISTR at NMAC #2024BHPS in Seattle on 4/19 to discuss how to leverage existing programs & systems to scale up #PrEP today to #endHIV : hivhep.org/Biomedical2024

While we appreciate President Biden’ budget continuing $$ for domestic #HIV & #hepatitis progs, w/o serious increases, we cannot #endHIV & #hepatitis by 2030: bit.ly/49ZoZei

First insulin, now inhalers. Three of the four big inhaler manufacturers capped out-of-pocket costs for their inhalers at $35 because of Democratic political pressure.

Teva — the fourth —should follow suit with an out-of-pocket cap.

Even more importantly, insurance companies…

Regulators urged to be more active in preventing health insurance discrimination: insurancenewsnet.com/innarticle/reg…

Learn how health centers, clinics, pharmacies, & health depts can increase #PrEP by leveraging existing programs & #insurance . Join HIV+Hepatitis Policy Institute Allies In Hope Houston @avitapharmacy Colorado Department of Public Health & Environment East Boston Neighborhood Health Center MISTR on 4/19 in Seattle: hivhep.org/Biomedical2024

While flat funding does not expand our efforts to prevent & treat #HIV or get us closer to #endHIV , it is much better than the alternative we have been facing, which was cutting vital HIV services & jeopardizing people’s lives: bit.ly/3INsMji

The #NBPP2025 is a tale of 2 rules: the fed gov WON’T enforce court victory making #allcopayscount toward #outofpocket costs for #patients but WILL prevent individual & small group plans from designating #Rx as non-EHB: bit.ly/3vEnuDS

We strongly support RI’s H 8041, authored by Mia Ackerman, which protects #patients by requiring that #Rx manufacturer #copayassistance counts toward #outofpocket expenses & prevents #insurers from double-dipping: bit.ly/49j3PHe

Congratulations to Francisco Ruiz, MS, for being selected as the new Director of the The White House's Office of National AIDS Policy (ONAP).

Read the White House's message at brnw.ch/21wIClL

These Employers Work with Vendors (& #PBMs ) that Designate Certain #Rx ’s as “Non-Essential Health Benefits” & Extract Copay Assistance meant for Patients for Themselves. U.S. Department of Labor must #ProtectACA : bit.ly/3vEnuDS

Everyone agrees that #patients are having trouble affording their #Rx ’s, that #copayassistance helps them, & #insurers are pocketing copay assistance w/o crediting #patients , but still the federal govt openly refuses to enforce court ruling: bit.ly/3vEnuDS

From Pink Sheet, Citeline Regulatory, Carl Schmid on the #NBPP2025 rule: “Patients are having trouble affording their #Rx , plans are pocketing #copayassistance w/o crediting #patients , & our federal govt openly refuses to enforce the court ruling” that #allcopayscount : bit.ly/3TIHrRJ

.HIV+Hepatitis Policy Institute criticized the federal govt for refusing to enforce the federal court ruling that #allcopayscount for #patients but praised the rule for ending the practice of non-essential health benefits #Rx in individual & small group #insurance mkts: bit.ly/3vEnuDS

Admin Silent On Co-Pay Accumulators In Final Exchange Reg, Advocates Eye Legal Options: insidehealthpolicy.com/daily-news/adm…